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1. Introduction 
BD is a prevalent mood disorder, often comorbid with other medical and psychiatric 
conditions and frequently misdiagnosed (Altamura et al., 2011a). Intense emotional states 
that occur in BD comprise manic, hypomanic, mixed or depressive episodes. According to 
the Diagnostic and Statistical Manual of Mental Disorders, IVth edition, text revision (DSM- 
IV–TR; American Psychiatric Association, 2000), BD spectrum ranges from cyclothymia to 
Bipolar I, Bipolar II Disorder and Not Otherwise Specified (NOS) forms. BD can also be 
conceptualized as a gradual change in mood scale, which ranges from severe depression to 
severe mania with an intermediate euthymic state or balanced mood. 
Dysthymia is a chronic state of mild low mood occurring for a minimum of two years. At 
the other end of the scale there is hypomania and severe mania. An alternative and broader 
dimensional approach conceptualizes BD as a continuum, between unipolar depression, 
schizoaffective disorder (which is considered by some authors a subcategory of BD) and 
schizophrenia. This theory may be supported from a clinical point of view by the fact that, 
sometimes, during severe manic, mixed or depressive episodes, bipolar patients experience 
psychotic symptoms, such as hallucinations or delusions. It is also supported by the 
presence of morphometric alterations of frequent observation among major psychoses, such 
as enlarged ventricles and white matter volume reductions in the left and temporoparietal 
regions (Czobor et al., 2007).  
In BD, symptomatic states are frequently associated with poor working functioning and 
social impairment. Bipolar patients, moreover, have higher suicide rates than the general 
population and among the highest of psychiatric patients. In a recent study on factors 
predicting suicide in BD, white race, family history of suicide, and previous cocaine abuse 
were considered predictive of suicidal behaviour (Cassidy, 2011). Usually BD develops in 
early adulthood/late teens, with an age of onset ranging from 15 to 50 years (Cassano et 
al., 2006). 
International treatment guidelines for BD recommend the use of mood stabilizers - either in 
monotherapy or in association - as the gold standard in both acute and long-term therapy. 
The concept of stabilization, in fact, has been stressed as the ultimate objective of the 
treatment of BD, given the chronic and recurrent nature of the illness, which accounts for its 
significant levels of impairment and disability (Altamura et al., 2011b). Beyond the 
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aforementioned core mood symptoms and clinical features of BD, over the last decade, 
neurocognitive dysfunction has been stressed as another nuclear dimension of BD and, 
possibly, a marker of its underlying pathophysiology (Lewandowski et al., 2010). There is 
accumulating evidence that individuals with BD have neurocognitive impairment that 
persists even during euthymia: the degree of impairment is more severe in patients with 
depressive symptoms, with functions associated with processing speed and attentional 
control being particularly implicated (Chaves et al., 2011; Van der Werf-Eldering et al., 
2010). In addition, in older euthimic adults with BD, resting-state corticolimbic 
dysregulation was related to sustained attention deficits and inhibitory control, which could 
reflect the cumulative impact of repeated affective episodes upon cerebral metabolism and 
neurocognitive performance (Brooks et al., 2011). Cognitive impairment in BD is influenced 
by the severity of illness  (Yates et al., 2010).  
In addition, neuropsychological and imaging studies in BD suggested the presence of 
cognitive deficits and subtle magnetic resonance imaging (MRI) changes in limbic areas that 
may persist over euthymia. However, other studies are inconsistent with this claim. For 
example, a recent study did not identify any difference between  BD patients and controls in 
levels of cognition over a two-year period, indicating that BD doesn’t have a significant 
adverse impact on cognition (Delaloye et al., 2011). 
Neuroimaging has recently gained an important role both in clinical practice and research of 
psychiatric disorders, including BD. Structural imaging techniques such as computed 
tomography (CT), magnetic resonance imaging (MRI) and magnetic resonance spectroscopy 
(MRS) have contributed to a deeper understanding of the structural changes in the brain in 
the context of psychiatric disorders. Positron Emission Tomography (PET), Single Photon 
Emission Computed Tomography (SPECT), Functional Magnetic Resonance Imaging (fMRI) 
and Diffusion Tensor Imaging (DTI) are techniques which measure changes in response to 
cognitive demand and/or connectivity between brain regions. As such, these approaches  
provide an opportunity for investigating the neural bases of behavioural and cognitive 
impairment  in psychiatric populations, including BD. 
2. Structural neuroimaging  
2.1 Computed Tomography (CT) 
In the last two decades, the first important data about neuroanatomic abnormalities in BD 
were obtained by means of CT. More recently, the widespread use of MRI has brought 
several advantages over CT, particularly in terms of higher resolution of images of 
subcortical regions (Steffens, 1998). Although a typical pattern of abnormality has not been 
identified yet (Supprian, 2004), several brain structures were found to be affected in patients 
with BD according to imaging studies.  
CT provides excellent imaging data and rapid image acquisition at relatively low cost, it is 
widely available and more easily tolerated by patients, remaining the imaging modality of 
first choice in many clinical situations (Dougherty et al., 2004). 
CT consists of a series of slices or tomograms. Its measurements are performed at the 
periphery of the body. The image of each slice is acquired by means of an X-ray source and 
detectors positioned at 180 degrees on the other side of the body. By spinning the source 
and the detectors on one plane of the head, data are collected from multiple angles. A 
computer then processes X-ray attenuation measured from different points and uses specific 
algorithms to create a structural image within the plane. Ionic and non-ionic intravenous 
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contrasts can be used to improve the visualization of certain normal or abnormal structures 
(Dougherty et al., 2004). 
The measurement of total brain volume and ventricular volumes has been the aim of the 
first investigations using CT in psychiatric disorders. In this perspective, less consistent 
results have been found for affective disorders compared to schizophrenia and dementia 
(Beyer et al., 2002). The limited number of controlled CT studies focused on bipolar patients, 
in fact, showed heterogeneous findings. These include increased lateral ventricle size 
compared to controls (Andreasen et al., 1990; Nasrallah et al., 1982; Pearlson et al., 1984) or, 
in contrast, non significant differences between patients and controls (Dewan et al., 1988; 
Schlegel et al., 1987; Young et al., 1999). A larger third ventricle has been reported as well 
(Dewan et al., 1988; Schlegel et al., 1987). Studies on cortical alterations in BD revealed that 
there was no significant difference between patients and controls with respect to the level of 
cortical atrophy (Iacono et al., 1988; Rieder et al., 1983; Schlegel et al., 1987). However, a 
positive correlation between increased cortical sulcal widening and age of onset/age of first 
manic episode has been observed in bipolar patients in a subsequent study (Young et al., 
1999). Volumetric changes in the cerebellum have been also reported, including higher rates 
of atrophy in bipolar patients (Nasrallah et al., 1982), even though the research of these 
abnormalities is limited.  
In synthesis, some studies using CT in bipolar patients found an increased lateral ventricles 
size. In addition, cortical atrophy (which was not statistically different from controls), 
atrophy in the cerebellum as well as a larger third ventricle have also been reported. 
2.2 Magnetic Resonance Imaging (MRI) 
MRI takes advantage of the magnetic properties of the atomic constituents of the tissues in 
order to create an image of the different parts of the body. Every MRI scanner has a static 
magnet; its strength usually ranges from 1.5 to 3 Tesla. A steady magnetic field is generated 
as an electric current passes through the coils. In order to have a nuclear magnetic resonance 
signal, only atomic nuclei with unpaired protons and/or neutrons can be used. Medical MRI 
uses essentially hydrogen (¹H) as it is widely diffused in the human body and it has only 
one proton in its nucleus. Each proton has its own magnetic field or dipole moment, 
induced by the rotation around its axis. When an externally magnetic field is applied, 
protons’ magnetic dipoles tend to align and to oscillate around the longitudinal axis of the 
applied field (this phenomenon is called precession) (Dougherty et al., 2004). 
An horizontal radio frequency (RF) pulse is applied perpendicularly to the longitudinal axis 
of the external magnetic field with the aim to create a transverse component to the 
magnetization vector. This induces the generation of an electric current which is transduced 
into an MRI image. T1 is the “longitudinal” relaxation time and it indicates the time 
required to regain longitudinal magnetization following RF pulse. T2 is the "transverse" 
relaxation time that measures how long the resonating protons precess "in phase" following 
a 90° RF pulse. Due to the T1 and T2 relaxation properties in MRI, differentiation between 
various tissues in the body is possible (Jezzard et al., 2001). 
Despite intensive research, to date no pathognomonic structural MRI finding has been 
correlated with affective disorders in general and to BD in particular. There are many 
heterogeneous data (Table 1) revealing a variety of structural alterations in bipolar patients 
(Dougherty et al., 2004). It must be considered, moreover, that some of these differences may 
be referred to the effects of medications (Van der Schot, 2009). For instance, chronic lithium 
treatment may prevent volume loss in treated patients because of its neuroprotective action 
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(Manji et al., 2000). Furthermore, genetic and/or environmental factors involved in BD may 
influence some brain abnormalities. In this perspective, decreases in white matter have been 
associated with the genetic risk of developing BD, whereas important environmental 
correlations have been found in relation to cortical gray matter volume (Van der Schot, 2009). 
Brain abnormalities reported by fMRI studies in patients with BD include changes in cortical 
volumes, cerebral white matter, cortical and prefrontal gray matter. Enlargement of the 
ventricles, dimensional modifications of the amygdala, nuclei of the basal ganglia, corpus 
callosum and cerebellum have also been detected. 
Main findings on lobar volumes concern frontal, temporal and insular cortex. Results on 
frontal lobes are quite discordant. In fact, they were found to be smaller (Coffman et al., 
1990; Schlaepfer et al., 1994) or of the same size as controls (Strakowski et al., 1999). With 
respect to temporal lobes, no differences (Johnstone et al. 1989), bilateral reduction of 
volume (Altshuler et al., 1991) or loss of normal symmetry were found. Even in terms of loss 
of symmetry of the temporal lobes findings were sometimes discordant. In fact, a study 
reported a larger right temporal lobe than the left one in male bipolar patients  (Swayze et 
al., 1992) and another study observed a larger left temporal lobe (Harvey et al., 1994). Voxel-
based morphometric (VBM) MRI studies showed an increased gray matter in the insular 
cortex (Lochhead et al., 2004) or non significant differences in this region (McDonald et al., 
2005; Nugent et al., 2006; Scherk et al., 2008a). An inverse correlation has been observed 
between the volume of the anterior insular cortex and the lifetime number of depressive 
episodes (Takahashy, 2010). 
Bipolar patients, in particular those with late onset, were found to have a higher incidence of 
subcortical hypertensities (Dupont et al., 1990; Figiel et al., 1991; McDonald et al., 1991; 
Norris et al., 1997; Soares & Mann, 1997; Stoll et al., 2000; Swayze et al.,1990; Videbech, 
1997). On the other hand, another study (Botteron & Figiel, 1997) identified an increased rate 
of white matter hyperintensity in relatively young individuals.  
Lateral ventricular enlargement has been observed in BD and associated with multiple 
episodes of mania (Strakowski et al., 2002). A larger third ventricle was reported in elderly 
depressive patients and in cases of first manic episode (Strakowski et al., 1993). Likewise, 
correlations have been found between third ventricle volume and psychotic symptoms, 
advanced age, late onset of the disease, male gender and positive dexamethasone 
suppression test (Benabarre et al., 2002). 
Studies on alterations of the amygdala in bipolar patients reported heterogeneous results, 
showing normal (Swayze et al., 1992), smaller (Pearlson et al., 1997) or larger volumes 
(Altshuler et al., 1998). More recent studies documented an increased volume in the right 
amygdala (Bremner et al., 2000), in bilateral amygdala in first episode subjects (Frodl et al., 
2002) and loss of normal symmetry (Mervaala et al., 2000). The heterogeneity of the adult 
studies may be referred to the different age of subjects. It is still unclear, however, the 
positive correlation between increased amygdala volume and age (Usher, 2010). 
A greater caudate volume as well as asymmetries among the structures of the basal ganglia 
were found in male bipolar patients (Aylward et al., 1994). Another study focused on the 
caudate volume in manic subjects in their first episode, reporting no significant differences 
vs healthy controls (Strakowski et al., 1999). The alterations may be attributed to a secondary 
effect of neuroleptic drugs (Benabarre et al., 2002). Studies examining alterations of the 
corpus callosum found volume reduction in bipolar patients, correlated with greater global 
neuropsychological dysfunction (Coffman et al., 1990). Finally, significant reduction of the 
cerebellar posterior vermis area was reported in patients with BD (DelBello et al., 1999). 
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Central nervous system structure 
involved 
Main MRI alterations in BD 
Frontal lobes Reduced or unchanged volume 
Temporal lobes Reduced or unchanged volume 
Loss of the symmetry 
Insular cortex Increased gray matter or no changes 
Subcortical areas Increased hyperintensities 
Lateral ventricles Increased (association with number of 
episodes of mania) 
Third ventricle Increased 
Amygdala Larger, smaller or unchanged volume 
Loss of normal symmetry 
Caudate nucleus Increased or unchanged volume 
Corpus callosum Reduced volume 
Cerebellar posterior vermis Reduced 
Table 1. Main MRI findings in BD. 
2.3 Magnetic Resonance Spectroscopy 
Magnetic Resonance Spectroscopy (MRS) is an MRI complement and serves as a non-
invasive tool for tissue characterization. While MRI uses the signal from hydrogen protons 
to create a visual representation of the tissues, proton MRS (1H- MRS) uses this information 
to determine the concentration of brain metabolites such as N-acetyl aspartate, choline, 
creatine and lactate in the examined tissue (Gujar et al., 2005).  
MRS has been principally used for the diagnosis of some metabolic disorders, especially 
those of the central nervous system. MRS has not an optimal specificity, but in association 
with MRI and clinical data can be very helpful. Indeed, the main purpose of this technique is 
to obtain biochemical information from any part of the body in a non invasive way, i.e. not 
by means of radioactive tracers or electromagnetic radiation (Dougherty et al., 2004).  
In psychiatry, MRS can be employed to assess the activity of different neurotransmitters, 
membrane and second messenger metabolism. The uniqueness of MRS is to provide an 
overview of the biochemical pathology of BD. Studies using proton MRS (1H- MRS) 
reported increased glutamate and GLX (glutamate, GABA and glutamine) levels in the 
dorsolateral prefrontal cortex, frontal lobes, basal ganglia and gray matter of medication-
free bipolar subjects and in patients with acute mania (Yildiz-Yesiloglu & Ankerst, 2006). 
Abnormal levels of N-acetyl aspartate, choline and myo-inositol have also been reported 
(Scherk et al., 2008b). N-acetyl aspartate seems to be reduced in the prefrontal cortex and 
hippocampus in bipolar individuals. Choline levels were found to be increased in the 
striatum and anterior cingulate cortex and can be normalized or decreased after treatment 
with antidepressants and lithium (Moore et al., 2000). Myo-inositol levels were increased in 
individuals with mania and euthymia and, on the contrary, reduced in bipolar depression.  
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Studies using phosphorus MRS (31P- MRS) have found phase-specific alterations of 
phospholipid membranes, high energy phosphates and intracellular brain pH in BD. In 
particular, a number of investigations reported a reduced intracellular cerebral pH in 
bipolar subjects which has been associated with the increased levels of lactate observed in 
some 1H- MRS studies. Both conditions are indicative of a shift from oxidative 
phosphorylation to glycolysis. There is also a 31P- MRS based-report of decreased levels of 
phosphocreatine and of phosphomonoesters in BD (Kato et al., 1995).  
Stork and Renshaw proposed a cohesive model that  puts together the majority of MRS 
findings. They hypothesized that the impaired oxidative phopshorilation, the decreased 
cellular energy and the altered membrane metabolism could be due to an underlying altered 
mitochondrial metabolism in BD (Stork & Renshaw, 2005). 
Main MRS findings in BD are synthetized in Table 2. 
 
Technique  Main alterations 
1H- MRS N- acetyl aspartate Reduced levels 
 Choline Increased levels 
 Glutamate, GABA and Glutamine  Increased levels 
 Myo-inositol Increased levels in 
mania and euthymia 
and reduced levels in 
bipolar depression 
 Lactate Increased levels 
31P- MRS Phosphocreatine Reduced levels 
 Phosphomonoesters Reduced levels 
 Intracellular brain pH Reduced levels 
Table 2. Main MRS findings in BD. 
3. Functional neuroimaging  
The major limitation of structural neuroimaging techniques is that they are suitable for 
studying diseases associated with morphologic alterations, such as neurologic conditions. 
For this reason, they are only partially useful in psychiatric disorders which are 
characterized by behavioral abnormalities due to neurochemical impairment. In this 
perspective, PET (Abraham & Feng, 2011) and fMRI represent the gold standard for brain 
imaging aimed to assess cognitive performance (Glower, 2011). Electroencefalography, 
Event-Related Potentials and Magnetoencephalography are less specific and, therefore, 
mostly used to exclude neurological conditions in clinical practice or for research purposes 
(Cohen & Cuffin, 1983). Medication, drug or alcohol abuse and genetic/epigenetic influence 
represent major confounding factors (Nakama et al., 2011; Schulte et al., 2010). On the other 
side, following the biopsychosocial model for psychiatric disorders, functional 
neuroimaging could help understanding the complex interaction between environmental 
stressors, genetic risk and precipitating events in the plasticity of neural circuitry and 
consequently in clinical symptoms.  
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Functional neuroimaging attempts to explain psychiatric disorders by means of 
degenerative or developmental model of illness and/or in terms of hypometabolism.  
In fact, elevated activity of the hippocampus or of the ventral prefrontal cortex as well as 
dorsolateral prefrontal cortex hypofunction are recurrent themes in literature (Savitz &  
Drevets, 2009).  
3.1 Positron Emission Tomography (PET) and Single Photon Emission Computed 
Tomography (SPECT)  
PET imaging is a direct measure of a radioactive decay due to cerebral metabolism of a 
radioactive substance or radionuclide. Different body tissues are characterized by different 
consumption rates of radionuclides (Ter-Pogossian et al., 1975; Vyas et al., 2011). 
Radionuclides used in clinical practice are usually major compounds of biologic molecules 
(18-Fluorine in the form of 18-Fluorodeoxyglucose or FDG for measuring glucose 
metabolism, 15-Oxygen for measuring blood flow, 11-Carbon or 13-Nitrogen common in 
diagnostic PET procedures). The nuclide is introduced in the patient and the radioactive 
decay is measured (Phelps et al., 1975): in particular, the positron emitted by nuclides has a 
collision with electrons producing a gamma photon which is measured by the PET camera 
(Roncali & Cherry, 2011). PET can measure both blood flow and glucose metabolism, often 
used as surrogate measures of neuronal synaptic activity. A first line comparison is between 
the neuroligand uptake in target regions and reference area while a more complex analysis 
can compare blood flow or glucose uptake in the same subject in different states, i.e. while 
resting or during a cognitive performance. Both ways provide useful data for research and 
clinical analysis; anyway, a major limitation is the use of a radioactive nuclide. Specifically, 
targeted PET radioligands are used to investigate neurotransmitter systems (Weisel, 1989). 
Cerebral PET has its major use in neurological disease: excluding primary or secondary 
oncologic lesions, evaluation of dementia, confirming epilepsy or assessing the state in 
cerebrovascular disease (Cavalcanti et al., 2011; Mazzuca et al., 2011; Person et al., 2010; 
Quigley et al., 2010; Salas and Gonzales, 2011). 
SPECT works capturing orbiting electrons without a positron-electron collision, but by 
means of an emission of a single photon  by the SPECT nuclide. Main nuclides used in 
SPECT are 123-Iodine, 33-Technetium or 133-Xenon. Single photons are selected with the 
use of multiple collimators.  
PET and SPECT studies in depressive disorders have shown that blood rate and flow are 
increased both in BD and in unipolar depression in the frontal lobes during depressive 
episodes. However, they are increased during mania in the dorsal cingulate cortex, striatal 
regions, and the nucleus accumbens, as well as in limbic structures of the temporal lobes 
and reduced in dorsolateral prefrontal cortex, possibly reflecting its loss of modulatory 
control over limbic structures (Gonul et al., 2009).  
With respect to neurotransmitters, serotonin (5-HT) transporter was found to have an 
increased density in the thalamus (Laje et al., 2010), dorsal cingulate cortex, medial 
prefrontal cortex and insula of depressed BD patients. 5-HT has been implicated in mania as 
well: in particular, individuals with current mania had significantly lower 5-HT2 receptor 
binding potential in frontal, temporal, parietal and occipital cortical regions, with more 
prominent changes in the right cortical regions compared to controls (Yatham et al., 2010, 
2002a, 2002b). With regards to 5-HT1A receptor, bipolar depressed patients were found to 
show higher 5-HT1A in raphe nuclei and forebrain (Sullivan et al., 2009). An interesting use 
of PET consists of assessing the role of serotonin in major depressive episodes comparing 
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BD vs unipolar depression. In fact, both unipolar and bipolar depression were associated 
with elevated 5-HT transporter binding in the insula, thalamus and striatum, but showed 
distinct abnormalities in the brainstem (Cannon et al., 2007).  
With respect to dopamine, D1 receptor binding potentials were found to be reduced in 
frontal cortex, even though striatal D2 receptor density was normal in all phases of non-
psychotic BD (Bauer, 2003; Suhara et al., 1992). 
In synthesis, PET and SPECT studies have shown in BD a loss of modulatory control of the 
cortex over limbic structures, reflected by specific phase-dependent modifications of blood 
rate and flow. Alterations of neurotransmitters involved in the pathogenesis of BD have also 
been reported, particularly with respect to serotonin transporter, serotonin receptor density 
and dopamine receptor density. 
3.2 Functional Magnetic Resonance Imaging (fMRI) 
FMRI is the most used technique in brain mapping and in psychiatric research due to its 
non-invasive technology, wide availability, high spatial and temporal resolution and the 
lack of ionizing radiation that allows the clinician to repeat functional exams over time as 
well as in different phases of illness. FMRI, in fact, is suitable for studying bipolar patients’ 
performances on the same cognitive tasks during depressed, manic or euthymic phases. It 
can also compare brain activity during symptom exacerbation as well as over periods of 
remission. 
One limit of fMRI is that it gives limited information on subcortical structures. Spatial 
resolution remains anyway highly relevant for the study of psychiatric diseases, given the 
clear correlation between cortical dysfunction and many psychiatric symptoms. Another 
limit consists of the increased variance of the results obtained with this technique in 
psychiatric patients (Dougherty et al., 2004). 
FMRI measures changes in blood flow in areas of the central nervous system (Konarsky et 
al., 2007). The hemodynamic response reflects neural activity in the brain or spinal cord as 
neurons have no reserve for oxygen or glucose and they need to rapidly increase blood flow 
when necessary. A Blood-oxygen-level dependent (BOLD) signal is measured by fMRI. 
From a physiological perspective, hemoglobin is diamagnetic when oxygenated 
(oxyhemoglobin) and paramagnetic when deoxygenated (deoxyhemoglobin) producing 
different signals that are higher when coming from activated areas. Actually, an increase in 
cerebral blood flow produces changes in oxygen consumption resulting in increased BOLD 
signals (Bandettini, 2003). 
Studies with fMRI in bipolar patients showed various alterations of the activity in different 
regions of the cortico-limbic pathways responsible for emotional regulation: amygdala,  
thalamus, striatum, portions of the prefrontal cortex and anterior cingulated cortex. Studies, 
however, were limited by the small samples size and by the possible interference of the 
medication. The increased activation of amygdala, striatum and thalamus were the most 
constant findings among the different studies (Cerullo et al., 2009).  
Increased amygdala and subcortical activity to emotional stimuli, in particular negative 
stimuli, as well as reduced activity of the prefrontal cortical regions during cognitive 
performances are common to all phases of BD, suggesting that they may be trait features of 
the disease (Phillips & Vieta, 2007). Other additional frontal and temporal regions were 
found to be activated, maybe as a compensatory mechanism (Townsed et al., 2010). 
FMRI studies in bipolar patients also suggest the presence of phase-dependent 
abnormalities. In fact, bipolar depression is associated with attenuated bilateral orbitofrontal 
www.intechopen.com
 
Neuroimaging Data in Bipolar Disorder: An Updated View 
 
271 
or elevated left orbitofrontal activity. Right dorsolateral prefrontal cortical activity was 
found to be reduced, while the increased left prefrontal activity seems to be a state marker of 
bipolar depression (Altshuler et al., 2008).  
The few studies with fMRI on manic patients report an increased activity of the amygdala, 
insular cortex and subcortical areas in response to negative emotional stimuli. Ventral 
striatal activity was found to be elevated at rest and during motor tasks. On the other hand, 
ventral prefrontal activity was found to be attenuated during cognitive performances 
(Altshuler et al., 2005; Elliott et al., 2004). In addition, bilateral orbitofrontal attenuation has 
been reported in mania and may represent a trait feature of the disorder as it is also present 
during bipolar depression (Altshuler et al., 2008). 
 
BD Phase Central nervous system
structures involved 
Main fMRI alterations 
Bipolar 
depression 
Orbitofrontal cortex Activity reduced bilaterally or 
increased on the left 
 Prefrontal cortex Reduced right activity; 
Increased left activity 
Mania Amygdala
Insula 
Subcortical areas 
Increased activity in response 
to negative stimuli 
 Ventral prefrontal cortex Reduced activity during 
cognitive performances 
 Orbitofrontal cortex Reduced activity bilaterally 
Euthymia Ventral prefrontal cortex
Anterior cingulate gyrus 
Reduced activity during 
attentional tasks 
 Dorsolateral prefrontal cortex Increased (i.e. during 
attentional tasks) or reduced 
activity (i.e. in response to 
fearful stimuli, during 
working memory tasks) 
 Subcortical areas Increased activity during 
performance or working 
memory tasks 
 Amygdala Increased activity in response 
to fearful stimuli 
 Striatum Increased activity in response 
to fearful stimuli; 
Significantly increased activity 
in response to reward stimuli 
Table 3. Main fMRI findings in BD. 
Findings on euthymic bipolar patients are more consistent and have pointed out reduced 
activity in dorsal, ventral prefrontal cortical regions and dorsal regions of the anterior 
cingulate gyrus during performance of attentional tasks. Dorsolateral prefrontal cortical 
activity was found to be, on the contrary, increased. Other studies have reported reduced 
dorsolateral prefrontal cortex activity in euthymic individuals during working memory and 
verbal encoding tasks (Deckersbach et al, 2006; Monks et al., 2004). Increases in activity 
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within subcortical regions associated with emotion processing rather than working memory 
or attention have also been detected in remitted, euthymic individuals with BD during 
performance of a continuous performance task (Strakowski et al., 2004) and  working 
memory task (Adler et al., 2004). Other studies investigated the response of the activity of 
these structures to fearful expressions in remitted bipolar patients. Results showed an 
increased activity in the amygdala and in the striatum and, on the other hand, a reduction of 
the dorsolateral prefrontal cortex activity (Phillips & Vieta, 2007). Of note, striatal activity in 
response to potentially rewarding stimuli was found to be significantly elevated. Other 
emotional stimuli led to decreased dorsolateral prefrontal cortical activity. These two 
patterns may underlie mood instabilities in euthymic patients, especially in those with 
comorbidities (Hassel et al., 2008).  
In synthesis, fMRI findings in bipolar patients are heterogeneous: they may be present in all 
phases of BD and/or can be phase-dependent. Among the formers, the most significant data 
include an increased activity of the amygdala and of the subcortical areas to negative stimuli 
and a reduced activity of the prefrontal cortex during cognitive tasks. Bipolar depression 
has been associated with modifications of the activity of the orbitofrontal and prefrontal 
cortex. In mania, specific alterations include an increased activity of the striatum at rest and 
during motor tasks and a reduction of the prefrontal cortex activity during cognitive 
performances. There are several studies on euthymic patients showing modifications of the 
activity of the prefrontal cortex during attentional or working memory tasks. Structures 
implicated in the emotional processing seem to be involved as well: in fact, modifications of 
the activity of the  amygdala, striatum and dorsolateral prefrontal cortex in response to 
different emotional stimuli have been reported. 
3.3 Diffusion Tensor Imaging (DTI)  
Diffusion tensor imaging (DTI) is an MRI application developed in order to investigate 
white matter connections between regions of interest. These connections provide 
information on functional activity between areas of the central nervous system. DTI is 
particularly useful to detect white matter lesions or dysfunction (Versace et al., 2008).  
There are few studies with DTI in BD, most of them based on the promising results from 
MRI research showing microstructural alterations in white matter in various neocortical 
areas and in the corpus callosum. In particular, fractional anisotropy, the most sensitive DTI 
marker which reflects fiber density, axonal diameter and myelination in white matter, was 
found to be decreased significantly in the ventral part of the corpus callosum in patients 
with BD (Heller et al., 2011). Other interesting results coming from DTI revealed that gray 
matter concentration was reduced in BD in the right anterior insula, head of the caudate 
nucleus, nucleus accumbens, ventral putamen and frontal orbital cortex. Other studies 
pointed out that BD patients showed abnormalities within white matter tracts connecting 
the frontal cortex with the temporal and parietal cortices and the fronto-subcortical circuits 
(Lin et al., 2011). White matter abnormalities seem to persist by the time of remission even 
after the first manic episodes (Chan et al., 2010), suggesting that disruption of white matter 
cortical-subcortical networks as well as projection, associative and commissural tracts may 
be a hallmark of the illness (Heng et al., 2010) involving prefrontal and frontal regions, 
associative and commissural fibres.  
Some recent studies reported that certain variants of BD may be due to an increased 
functional or effective connectivity between orbitofrontal and temporal pole structures in 
the dominant hemisphere. The orbitofrontal cortex codifies the value of different stimuli, 
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allowing goal and sub-goal structuring. Moreover, it is involved in reward prediction. On 
the other hand, the temporal pole seems to be activated in basic semantic processes with 
person-emotion linkages associated with narrative. BD patients have a  deficit of 
performance on visuospatial and constructional praxis which suggests an atypical 
localization of cognitive functions. This atypical localization and the hyperconnectivity 
between specific regions could be responsible for the enhanced creativity and writing ability 
observed in BD probands (McCrea, 2008). 
Recently, abnormalities in perigenual anterior cingulate cortex-amygdala functional 
connectivity during emotional processing  have been found in BD (Wang et al., 2009). 
Similar findings have been reported even in children and adolescents with BD, concluding 
that in these subjects significant white matter tract alterations were present in regions 
involved in emotional, behavioural and cognitive regulation. In addition, these results 
suggest that alterations in white matter are present early in the course of disease in familial 
BD (Barnea-Goraly et al., 2009; Kavafaris et al., 2009). An impaired fiber density in anterior 
corona radiata (as detected with a decreased fractional anisotropy) was detected in BD in 
pediatric age and in Attention Deficit and Hyperactivity Disorder suggesting a possible link 
between the two disorders (Pavuluri et al., 2008).  
DTI studies can allow to detect a possible overlap between BD and schizophrenia. In fact, 
reduced integrity of the anterior limb of the internal capsule, uncinate fasciculus and 
anterior thalamic radiation regions is common to both schizophrenia and BD suggesting an 
overlap in white matter pathology, possibly relating to risk factors common to both 
disorders (Sussman et al., 2008). 
Concerning antidepressants and mood stabilizers, these compounds seem to have 
neuroprotective effects and are not likely to explain white matter abnormalities, even though 
minor effects cannot be excluded (Bruno et al., 2008). Anyway, microstructural abnormality in 
the white matter has been associated with a low remission rate of major depression. 
In synthesis, DTI provides information on functional connectivity between regions of the 
central nervous system. DTI studies on bipolar probands showed a reduced gray matter in 
areas such as putamen, caudate nucleus, nucleus acumbens, insula and orbitofrontal cortex. 
As concerns white matter, connections between orbitofrontal cortex, temporal, parietal 
corteces and the frontosubcortical circuits were found to be altered during mania and also 
over euthymia, as possible traits of BD. DTI findings have interesting implications on the 
association between BD and creativity. The hyperconnectivity between specific regions and 
the atypical localization of cognitive functions seem to be correlated to the enhanced 
creativity and writing ability of BD subjects. On the other hand, the atypical localization of 
cognitive functions could underlie the visuoconstructional praxis deficit present in BD. 
4. Conclusions 
Since the introduction of CT, researchers focused their efforts in elucidating the connection 
between psychiatric diseases and the presence of structural cerebral alterations through 
neuroimaging. CT pioneered this research without providing, however, a complete answer. 
Actually, a growing body of evidence has been accumulated in literature as newer 
techniques such as MRI and functional imaging (i.e., SPECT, PET, fMRI) have been 
introduced revealing much about the biological underpinnings of neuropsychiatric 
disorders. Neuroimaging research in BD has already produced several data documenting 
the involvement of different cortical and subcortical regions in different phases of the 
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illness. In particular, published studies explored structural and functional abnormalities 
present in BD and tried to establish specific correlations with outcome (Moore et al., 2001; 
Wingo et al., 2009, Bearden, 2010) as well as difficult-to-treat conditions such as treatment 
resistant forms (Regenold et al., 2008).  
The possibility to study cognitive function in BD through fMRI represents another major 
acquisition of neuroimaging in psychiatric research. The attainment of this goal can be 
facilitated by identifying biomarkers reflecting pathophysiologic processes in BD, namely 
impaired emotion regulation, impaired attention, and distractibility, which persist during 
depression and remission and are not common to unipolar depression (Phillips & Vieta, 2007). 
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